{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:21Z","timestamp":1794047421664,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"7","license":[{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2022.281828","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T05:31:21Z","timestamp":1672291881000},"page":"1945-1950","source":"Crossref","is-referenced-by-count":4,"title":["A novel colony stimulating factor 3 receptor activating mutation identified in a patient with chronic neutrophilic leukemia"],"prefix":"10.3324","volume":"108","author":[{"given":"Breanna N.","family":"Maniaci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooho","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Sanz-Altamira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"DeAngelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Maxson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2022,12,29]]},"reference":[{"key":"49771","doi-asserted-by":"crossref","unstructured":"Beekman R, Valkhof M, van Strien P, Valk PJ, Touw IP. Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia. Haematologica. 2013; 98(5):e62-63.","DOI":"10.3324\/haematol.2013.085050"},{"key":"49772","doi-asserted-by":"crossref","unstructured":"Dong F, Brynes RK, Tidow N, Welte K, Lowenberg B, Touw IP. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med. 1995; 333(8):487-493.","DOI":"10.1056\/NEJM199508243330804"},{"key":"49773","doi-asserted-by":"crossref","unstructured":"Maxson JE, Gotlib J, Pollyea DA. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med. 2013; 368(19):1781-1790.","DOI":"10.1056\/NEJMoa1214514"},{"key":"49774","doi-asserted-by":"crossref","unstructured":"Pardanani A, Lasho TL, Laborde RR. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia. 2013; 27(9):1870-1873.","DOI":"10.1038\/leu.2013.122"},{"key":"49775","doi-asserted-by":"crossref","unstructured":"Maxson JE, Ries RE, Wang YC. CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML. Blood. 2016; 127(24):3094-3098.","DOI":"10.1182\/blood-2016-04-709899"},{"key":"49776","doi-asserted-by":"crossref","unstructured":"Lavallee VP, Krosl J, Lemieux S. Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors. Blood. 2016; 127(24):3054-3061.","DOI":"10.1182\/blood-2016-03-705053"},{"key":"49777","doi-asserted-by":"crossref","unstructured":"Touw IP, Palande K, Beekman R. Granulocyte colony-stimulating factor receptor signaling: implications for G-CSF responses and leukemic progression in severe congenital neutropenia. Hematol Oncol Clin North Am. 2013; 27(1):61-73.","DOI":"10.1016\/j.hoc.2012.10.002"},{"key":"49778","doi-asserted-by":"crossref","unstructured":"Maxson JE, Luty SB, MacManiman JD, Abel ML, Druker BJ, Tyner JW. Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization. J Biol Chem. 2014; 289(9):5820-5827.","DOI":"10.1074\/jbc.M113.508440"},{"key":"49779","doi-asserted-by":"crossref","unstructured":"Plo I, Zhang Y, Le Couedic JP. An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia. J Exp Med. 2009; 206(8):1701-1707.","DOI":"10.1084\/jem.20090693"},{"key":"49780","doi-asserted-by":"crossref","unstructured":"Spiciarich DR, Oh ST, Foley A. A novel germline variant in CSF3R reduces N-glycosylation and exerts potent oncogenic effects in leukemia. Cancer Res. 2018; 78(24):6762-6770.","DOI":"10.1158\/0008-5472.CAN-18-1638"},{"key":"49781","doi-asserted-by":"crossref","unstructured":"Maxson JE, Luty SB, MacManiman JD, Abel ML, Druker BJ, Tyner JW. Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization. J Biol Chem. 2014; 289(9):5820-5827.","DOI":"10.1074\/jbc.M113.508440"},{"key":"49782","doi-asserted-by":"crossref","unstructured":"Rohrabaugh S, Kesarwani M, Kincaid Z. Enhanced MAPK signaling is essential for CSF3R-induced leukemia. Leukemia. 2017; 31(8):1770-1778.","DOI":"10.1038\/leu.2016.376"},{"key":"49783","doi-asserted-by":"crossref","unstructured":"Dao KT, Gotlib J, Deininger MMN. Efficacy of ruxolitinib in patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia. J Clin Oncol. 2020; 38(10):1006-1018.","DOI":"10.1200\/JCO.19.00895"},{"key":"49784","doi-asserted-by":"crossref","unstructured":"Gotlib J, Maxson JE, George TI, Tyner JW. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment. Blood. 2013; 122(10):1707-1711.","DOI":"10.1182\/blood-2013-05-500959"},{"key":"49785","doi-asserted-by":"crossref","unstructured":"Carratt SA, Kong GL, Curtiss BM. Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms. Blood. 2022; 140(6):644-658.","DOI":"10.1182\/blood.2021014777"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.281828\/75199","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.281828\/75801","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10926\/75199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:03:08Z","timestamp":1794045788000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.281828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,29]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.281828","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,29]]}}}